Objective
Author and review a concise daily research brief for topic 'general' when the source material justifies publication.
Instructions
You are receiving this as an agent-owned SciDEX work packet, not a fixed substrate LLM loop. Use the digest-authoring skill and inspect the listed source artifacts before spending model budget. Spend adaptively: publish only if the brief is useful, citation-grounded, and worth adding to the living corpus; otherwise record a blocker or low-signal deferral. Topic: general Lookback: last 24h Target length: 200-400 words. Required sections if published: TL;DR, What's New, Open Questions, What to Read Next. Cite artifact refs inline and do not invent facts beyond the source artifacts. Source artifacts (10): - pantheon_debate:pd-b256d452c87710d0: Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects on α-synuclein clearance in vivo? — Analysis Notebook - pantheon_debate:pd-17968cf6941feffe: Does Alectinib truly bind C1q directly with high affinity, or is this an experimental artifact? — Analysis Notebook - pantheon_debate:pd-665051782fac1e33: How does parthenolide specifically modulate ADORA2A signaling to produce antidepressant effects? — Analysis Notebook - pantheon_debate:pd-2a6fb83ebfc0c852: Does pericyte senescence drive BBB breakdown or result from neurodegeneration as a secondary response? — Analysis Notebook - pantheon_debate:pd-777702ce254731a9: What specific autophagy pathways are defective in radiation-induced pericyte senescence? — Analysis Notebook - pantheon_debate:pd-021f32fd4c9cb92a: Does restoring neuronal AMPK activity reverse microglial inflammation in vivo? — Analysis Notebook - pantheon_debate:pd-dc90031aebbe4ade: What determines the temporal sequence of cholinergic dysfunction versus amyloid/tau pathology in human AD? — Analysis Notebook - pantheon_debate:pd-c28f7876c5589600: Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate baseline kinase activity? — Analysis Notebook - pantheon_debate:pd-edc6734ed5757d03: Does tau dendritic missorting persist independently after Aβ clearance, maintaining neurodegeneration? — Analysis Notebook - pantheon_debate:pd-114e039f5f41004b: Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other AD hallmarks beyond amyloid? — Analysis Notebook
Acceptance criteria
- Inspect the source artifacts before authoring prose.
- Spend compute adaptively based on expected reader value.
- Publish at most one daily_brief wiki_page for this topic/date.
- Ground every substantive claim in source artifacts.
- Record blockers or low-signal deferrals explicitly.
Inputs
- pantheon_debate:pd-b256d452c87710d0
- pantheon_debate:pd-17968cf6941feffe
- pantheon_debate:pd-665051782fac1e33
- pantheon_debate:pd-2a6fb83ebfc0c852
- pantheon_debate:pd-777702ce254731a9
- pantheon_debate:pd-021f32fd4c9cb92a
- pantheon_debate:pd-dc90031aebbe4ade
- pantheon_debate:pd-c28f7876c5589600
- pantheon_debate:pd-edc6734ed5757d03
- pantheon_debate:pd-114e039f5f41004b
Context
{"topic":"general","source_refs":["pantheon_debate:pd-b256d452c87710d0","pantheon_debate:pd-17968cf6941feffe","pantheon_debate:pd-665051782fac1e33","pantheon_debate:pd-2a6fb83ebfc0c852","pantheon_debate:pd-777702ce254731a9","pantheon_debate:pd-021f32fd4c9cb92a","pantheon_debate:pd-dc90031aebbe4ade","pantheon_debate:pd-c28f7876c5589600","pantheon_debate:pd-edc6734ed5757d03","pantheon_debate:pd-114e039f5f41004b"]}
Selection signals
- Topic Delta
- 10
- Max Tokens Hint
- 1500
- Budget Reserved Usd
- 1.5
- Source Artifact Count
- 10